SciSparc Ltd (SPRC) Quarterly EPS earnings growth

SciSparc Ltd - graphic logo of issuer SPRC

SciSparc Ltd is a reputable developer in neurology that synthesizes classical chemistry with cannabinoids. The company is currently focusing on its own tests of psychoactive compounds, limiting partnerships strictly to scientific alliances. Specialists are creating safe formulas to combat dementia and Tourette syndrome. The quarterly EPS dynamics reflect the financial condition, where 0.00 is the current value of the indicator.

SciSparc (SPRC) - Year-over-year earnings per one share growth for the last 12 months from 02/21/2024 to 11/15/2026

Summary analytical data breakdowns for SciSparc Ltd (SPRC)

- share price and consensus valuation forecast:
Stock Quotes scisparc.com|SPRC - Average Forecast Price
- market capitalization details:
Market Capitalization SciSparc Ltd.|SPRC - Real Price to Acquire Entire Company
- balance sheet net asset value indicators:
Book Value per Share SciSparc|SPRC - Accounting Value of Company|Market Value to Book Value Ratio scisparc.com|SPRC - Company Assets
- debt and liquidity details:
Debt to Equity SciSparc Ltd|SPRC - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital SciSparc Ltd.|SPRC - Company Total Debt|Debts to Book Capitalization SciSparc Ltd|SPRC - Long-Term Debt Volume|Company Short-Term Debt SciSparc|Quick Liquidity scisparc.com
- earnings and valuation multiples indicators:
SPRC - Profit After Tax|Projected Future Earnings SciSparc Ltd|SPRC - P/E Multiple|Future Price to Earnings SciSparc Ltd|SPRC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple SciSparc Ltd.|SPRC - Operating profit before deduction of amortization|Net earnings per share for the last 12 months SciSparc|SPRC - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months scisparc.com|SPRC - Earnings per share growth in current year|Expected earnings per share growth for next year SciSparc Ltd
- sales revenue and business income indicators:
SPRC - Company Total Sales|Projected Sales Volume SciSparc Ltd|SPRC - Market Cap to Revenue Ratio|Price-to-Projected Revenue Ratio SciSparc Ltd|SPRC - Annual Revenue Growth (Last Twelve Months)
Basic company analysis:SciSparc Corp - SPRC
Manufactured product of SciSparc Corp

The market evaluates the potential of SciSparc Ltd (SPRC) through the lens of future revenues from innovative autism therapy, which is reflected in the quarterly EPS dynamics profile. This indicator measures the percentage change in net income per share, allowing investors to distinguish random price spikes from the sustainable capitalization growth typical of biotech assets with long-term patent protection.

Competitors of SciSparc Ltd (SPRC)

ALKS (alkermes.com) - Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Avadel Pharma (AVDL)|ATAI (atai.life) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months GH Research PLC (GHRS)|Quarterly EPS earnings growth MNMD|CMPS (COMPASS Pathways PLC) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months lbpharma.us LBRX|Bright Minds Biosciences Inc (DRUG) - Earnings per share growth in annualized terms for the last twelve months|VNDA: Year-over-year net earnings per share growth for the last 12 months|Cybin Inc (CYBN) - Year-over-year net earnings per share growth for the last 12 months|Alto Neuroscience (ANRO) - Year-over-year earnings per share growth for the last twelve months|NRx Pharma - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Cingulate|Year-over-year earnings per share growth for the last twelve months SILO|Year-over-year earnings per share growth for the last twelve months China Pharma (CPHI)|Quarterly EPS earnings growth Clearmind Medicine, Inc. (CMND)|Quarterly EPS earnings growth PBM (Psyence Biomedical Ltd)|Seelos Therapeutics Inc. (SEEL) - Earnings per share growth in annualized terms for the last twelve months|VRPX: Year-over-year net earnings per share growth for the last 12 months|KRTX - Quarterly EPS earnings growth